BeyondSpring Inc. (NASDAQ:BYSI) Expected to Post Quarterly Sales of $7.66 Million

Wall Street brokerages predict that BeyondSpring Inc. (NASDAQ:BYSI) will report $7.66 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for BeyondSpring’s earnings, with the highest sales estimate coming in at $14.99 million and the lowest estimate coming in at $340,000.00. The company is scheduled to report its next earnings results on Tuesday, November 30th.

On average, analysts expect that BeyondSpring will report full-year sales of $15.33 million for the current fiscal year, with estimates ranging from $700,000.00 to $57.65 million. For the next financial year, analysts expect that the company will report sales of $121.50 million, with estimates ranging from $14.10 million to $261.10 million. Zacks’ sales calculations are a mean average based on a survey of analysts that that provide coverage for BeyondSpring.

BeyondSpring (NASDAQ:BYSI) last issued its quarterly earnings data on Thursday, September 9th. The company reported ($0.49) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.49). The business had revenue of $0.34 million during the quarter, compared to the consensus estimate of $13.84 million. During the same quarter in the previous year, the firm posted ($0.46) EPS.

BYSI has been the subject of a number of recent research reports. Evercore ISI restated a “buy” rating on shares of BeyondSpring in a research report on Thursday, August 19th. Zacks Investment Research upgraded BeyondSpring from a “sell” rating to a “hold” rating in a research report on Monday. Robert W. Baird initiated coverage on BeyondSpring in a research report on Wednesday, September 8th. They set an “outperform” rating and a $50.00 target price for the company. William Blair restated a “buy” rating on shares of BeyondSpring in a research report on Friday, August 27th. Finally, HC Wainwright decreased their price objective on BeyondSpring from $100.00 to $65.00 and set a “buy” rating for the company in a research note on Monday, September 20th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $49.40.

Shares of BYSI stock traded up $0.62 on Friday, reaching $13.28. 883,973 shares of the stock were exchanged, compared to its average volume of 1,195,248. The stock has a market cap of $519.33 million, a PE ratio of -6.88 and a beta of 1.03. BeyondSpring has a one year low of $8.90 and a one year high of $33.00. The stock has a 50 day moving average price of $15.38 and a 200 day moving average price of $15.24.

Institutional investors have recently made changes to their positions in the stock. Legal & General Group Plc grew its stake in BeyondSpring by 22.7% in the second quarter. Legal & General Group Plc now owns 2,403 shares of the company’s stock valued at $25,000 after acquiring an additional 445 shares during the period. Meeder Asset Management Inc. grew its stake in BeyondSpring by 88.8% in the second quarter. Meeder Asset Management Inc. now owns 3,631 shares of the company’s stock valued at $38,000 after acquiring an additional 1,708 shares during the period. US Bancorp DE grew its stake in BeyondSpring by 3,629.9% in the third quarter. US Bancorp DE now owns 2,499 shares of the company’s stock valued at $39,000 after acquiring an additional 2,432 shares during the period. Citigroup Inc. grew its stake in BeyondSpring by 139.8% in the third quarter. Citigroup Inc. now owns 2,556 shares of the company’s stock valued at $40,000 after acquiring an additional 1,490 shares during the period. Finally, Royal Bank of Canada lifted its holdings in shares of BeyondSpring by 72.1% in the third quarter. Royal Bank of Canada now owns 2,640 shares of the company’s stock valued at $42,000 after purchasing an additional 1,106 shares in the last quarter. 19.11% of the stock is owned by institutional investors and hedge funds.

About BeyondSpring

BeyondSpring, Inc engages in the the development and commercialization of immuno-oncology cancer therapies to improve clinical outcomes for patients who have high unmet medical needs. It operates through PRC and U.S. geographical segments. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.

Featured Article: What is Liquidity?

Get a free copy of the Zacks research report on BeyondSpring (BYSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for BeyondSpring (NASDAQ:BYSI)

Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.